194 related articles for article (PubMed ID: 28615299)
1. Ormeloxifene Suppresses Prostate Tumor Growth and Metastatic Phenotypes via Inhibition of Oncogenic β-catenin Signaling and EMT Progression.
Hafeez BB; Ganju A; Sikander M; Kashyap VK; Hafeez ZB; Chauhan N; Malik S; Massey AE; Tripathi MK; Halaweish FT; Zafar N; Singh MM; Yallapu MM; Chauhan SC; Jaggi M
Mol Cancer Ther; 2017 Oct; 16(10):2267-2280. PubMed ID: 28615299
[TBL] [Abstract][Full Text] [Related]
2. Suppression of Akt1-β-catenin pathway in advanced prostate cancer promotes TGFβ1-mediated epithelial to mesenchymal transition and metastasis.
Gao F; Alwhaibi A; Sabbineni H; Verma A; Eldahshan W; Somanath PR
Cancer Lett; 2017 Aug; 402():177-189. PubMed ID: 28602980
[TBL] [Abstract][Full Text] [Related]
3. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
Al-Azayzih A; Gao F; Somanath PR
Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
[TBL] [Abstract][Full Text] [Related]
4. Anti-EMT properties of CoQ0 attributed to PI3K/AKT/NFKB/MMP-9 signaling pathway through ROS-mediated apoptosis.
Yang HL; Thiyagarajan V; Shen PC; Mathew DC; Lin KY; Liao JW; Hseu YC
J Exp Clin Cancer Res; 2019 May; 38(1):186. PubMed ID: 31068208
[TBL] [Abstract][Full Text] [Related]
5. Targeting the SPOCK1-snail/slug axis-mediated epithelial-to-mesenchymal transition by apigenin contributes to repression of prostate cancer metastasis.
Chien MH; Lin YW; Wen YC; Yang YC; Hsiao M; Chang JL; Huang HC; Lee WJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):246. PubMed ID: 31182131
[TBL] [Abstract][Full Text] [Related]
6. Quercetin modulates Wnt signaling components in prostate cancer cell line by inhibiting cell viability, migration, and metastases.
Baruah MM; Khandwekar AP; Sharma N
Tumour Biol; 2016 Oct; 37(10):14025-14034. PubMed ID: 27495232
[TBL] [Abstract][Full Text] [Related]
7. Ormeloxifene suppresses desmoplasia and enhances sensitivity of gemcitabine in pancreatic cancer.
Khan S; Ebeling MC; Chauhan N; Thompson PA; Gara RK; Ganju A; Yallapu MM; Behrman SW; Zhao H; Zafar N; Singh MM; Jaggi M; Chauhan SC
Cancer Res; 2015 Jun; 75(11):2292-304. PubMed ID: 25840985
[TBL] [Abstract][Full Text] [Related]
8. Arenobufagin inhibits prostate cancer epithelial-mesenchymal transition and metastasis by down-regulating β-catenin.
Chen L; Mai W; Chen M; Hu J; Zhuo Z; Lei X; Deng L; Liu J; Yao N; Huang M; Peng Y; Ye W; Zhang D
Pharmacol Res; 2017 Sep; 123():130-142. PubMed ID: 28712972
[TBL] [Abstract][Full Text] [Related]
9. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
[TBL] [Abstract][Full Text] [Related]
10. Wogonoside Inhibits Prostate Cancer Cell Growth and Metastasis via Regulating Wnt/β-Catenin Pathway and Epithelial-Mesenchymal Transition.
Wei C; Jing J; Zhang Y; Fang L
Pharmacology; 2019; 104(5-6):312-319. PubMed ID: 31480051
[TBL] [Abstract][Full Text] [Related]
11. Baicalein suppresses metastasis of breast cancer cells by inhibiting EMT via downregulation of SATB1 and Wnt/β-catenin pathway.
Ma X; Yan W; Dai Z; Gao X; Ma Y; Xu Q; Jiang J; Zhang S
Drug Des Devel Ther; 2016; 10():1419-41. PubMed ID: 27143851
[TBL] [Abstract][Full Text] [Related]
12. Toosendanin suppresses oncogenic phenotypes of human gastric carcinoma SGC‑7901 cells partly via miR‑200a‑mediated downregulation of β-catenin pathway.
Wang G; Huang YX; Zhang R; Hou LD; Liu H; Chen XY; Zhu JS; Zhang J
Int J Oncol; 2017 Nov; 51(5):1563-1573. PubMed ID: 29048657
[TBL] [Abstract][Full Text] [Related]
13. Cinobufacini Inhibits Colon Cancer Invasion and Metastasis via Suppressing Wnt/β-Catenin Signaling Pathway and EMT.
Wang J; Cai H; Liu Q; Xia Y; Xing L; Zuo Q; Zhang Y; Chen C; Xu K; Yin P; Chen T
Am J Chin Med; 2020; 48(3):703-718. PubMed ID: 32329642
[TBL] [Abstract][Full Text] [Related]
14. Hsp27 regulates EGF/β-catenin mediated epithelial to mesenchymal transition in prostate cancer.
Cordonnier T; Bishop JL; Shiota M; Nip KM; Thaper D; Vahid S; Heroux D; Gleave M; Zoubeidi A
Int J Cancer; 2015 Mar; 136(6):E496-507. PubMed ID: 25130271
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-150 suppresses epithelial-mesenchymal transition, invasion, and metastasis in prostate cancer through the TRPM4-mediated β-catenin signaling pathway.
Hong X; Yu JJ
Am J Physiol Cell Physiol; 2019 Apr; 316(4):C463-C480. PubMed ID: 30566393
[TBL] [Abstract][Full Text] [Related]
17. Cardamonin, a chalcone, inhibits human triple negative breast cancer cell invasiveness by downregulation of Wnt/β-catenin signaling cascades and reversal of epithelial-mesenchymal transition.
Shrivastava S; Jeengar MK; Thummuri D; Koval A; Katanaev VL; Marepally S; Naidu VGM
Biofactors; 2017 Mar; 43(2):152-169. PubMed ID: 27580587
[TBL] [Abstract][Full Text] [Related]
18. Selenium-enriched polysaccharides from Pyracantha fortuneana (Se-PFPs) inhibit the growth and invasive potential of ovarian cancer cells through inhibiting β-catenin signaling.
Sun Q; Dong M; Wang Z; Wang C; Sheng D; Li Z; Huang D; Yuan C
Oncotarget; 2016 May; 7(19):28369-83. PubMed ID: 27058760
[TBL] [Abstract][Full Text] [Related]
19. Mangiferin exerts antitumor activity in breast cancer cells by regulating matrix metalloproteinases, epithelial to mesenchymal transition, and β-catenin signaling pathway.
Li H; Huang J; Yang B; Xiang T; Yin X; Peng W; Cheng W; Wan J; Luo F; Li H; Ren G
Toxicol Appl Pharmacol; 2013 Oct; 272(1):180-90. PubMed ID: 23707762
[TBL] [Abstract][Full Text] [Related]
20. Luteolin suppresses the metastasis of triple-negative breast cancer by reversing epithelial-to-mesenchymal transition via downregulation of β-catenin expression.
Lin D; Kuang G; Wan J; Zhang X; Li H; Gong X; Li H
Oncol Rep; 2017 Feb; 37(2):895-902. PubMed ID: 27959422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
